M
MPCi
Activity from announced rounds
Activity in this selectionSingapore
MPCi is the China-focused investment manager identified by its own site and by Tripo, Aureka and Excalipoint announcements.
Recorded funding activity
Tripo develops generative 3D tools. Aureka builds biological models and discovery infrastructure, while Excalipoint develops T-cell therapies. The manager remains distinct from US Matrix and independently operated regional firms.
- Rounds participated in
- 0
- Confirmed lead rounds
- — All roles disclosed
- New companies
- 0 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share
By stage
No activity in this selection.
By primary sector
No activity in this selection.
By country
No activity in this selection.
Rounds
0 in this selectionNo rounds match this selection.